BioCentury | Aug 27, 2020
Distillery Therapeutics

siRNAs against plaque-destabilizing molecule CAMK2G for atherosclerosis

...Sci. Transl. Med.; published online July 22, 2020doi:10.1126/scitranslmed.aay1063CONTACT: Omid C. Farokhzad, Brigham and Women’s Hospital, Harvard Medical School...
...affiliation as aboveemail: jshi@bwh.harvard.eduCONTACT: Ira Tabas, Columbia University Irving Medical Center, New York, N.Y.email: iat1@columbia.edu Claire Quang Harvard Medical School Columbia...
BioCentury | Aug 27, 2020
Translation in Brief

AbbVie, Harvard in $30M emerging infections partnership, Peel’s cancer therapy from CHOP and Stoke’s Dravet therapy

...Sodium voltage-gated channel alpha subunit 1 Danielle Golovin Stoke Therapeutics Inc. Peel Therapeutics Inc. Children's Hospital of Philadelphia AbbVie Inc. Harvard University Harvard Medical School Sodium...
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...III trial of Moderna’s COVID-19 vaccine, mRNA-1273. Nabel is also a professor of medicine at Harvard Medical School...
BioCentury | Jul 25, 2020
Translation in Brief

New class of cytosine base editors; plus new U.K. vaccine manufacturing facilities, scalable surrogate assay for COVID-19; combating antibiotic resistance and

...SARS-CoV-2 spike protein Danielle Golovin, Staff Writer Chinese Academy of Sciences Agency for Science Technology and Research Massachusetts General Hospital Harvard Medical School Beam...
BioCentury | Jul 23, 2020
Emerging Company Profile

On track for 2021 launch, Seer unveils unbiased proteomics tech and latest $55M round

...City, Calif. Technology: Nanoparticle-based unbiased proteomics assay system Origin of technology: Brigham and Women’s Hospital, Harvard Medical School...
...Founded: 2017 by Omid Farokhzad, Philip Ma, Robert Langer University collaborators: Massachusetts Institute of Technology, Harvard Medical School...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...investigator at the Healey Center for ALS at Mass General and an assistant professor at Harvard Medical School...
BioCentury | Jun 26, 2020
Distillery Therapeutics

AADAC identified as protective factor against diabetic atherosclerosis

...published online May 14, 2020 doi:10.1016/j.stem.2020.04.018 CONTACT: Takafumi Toyohara, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School...
...Center (BIDMC), Harvard Medical School, Boston, Mass.; Harvard University, Cambridge, Mass. email: ccowan@fas.harvard.edu Claire Quang Beth Israel Deaconess Medical Center Harvard Medical School...
BioCentury | Jun 26, 2020
Distillery Therapeutics

Biocryst’s galidesivir effective against Zika in macaques

...published online June 10, 2020 doi:10.1126/scitranslmed.aau9135 CONTACT: James B. Whitney, Beth Israel Deaconess Medical Center, Harvard Medical School...
...Institute of MGH, MIT and Harvard, Cambridge, Mass. email: jwhitne2@bidmc.harvard.edu Claire Quang galidesivir (BCX4430) Beth Israel Deaconess Medical Center Harvard Medical School BioCryst...
BioCentury | Jun 23, 2020
Distillery Therapeutics

Blocking cGAS signaling for alcohol-related liver disease

...Massachusetts General Hospital, Harvard Medical School, Boston, Mass.; Beth Israel Deaconess Medical Center, Boston, Mass. email: sjpatel32@mgh.harvard.edu Claire Quang Harvard Medical School Massachusetts...
BioCentury | May 23, 2020
Product Development

A guide to serum virus neutralization assays

...least 80 if no alternatives are available. On Thursday, a group led by scientists at Harvard Medical School’s...
Items per page:
1 - 10 of 1510
BioCentury | Aug 27, 2020
Distillery Therapeutics

siRNAs against plaque-destabilizing molecule CAMK2G for atherosclerosis

...Sci. Transl. Med.; published online July 22, 2020doi:10.1126/scitranslmed.aay1063CONTACT: Omid C. Farokhzad, Brigham and Women’s Hospital, Harvard Medical School...
...affiliation as aboveemail: jshi@bwh.harvard.eduCONTACT: Ira Tabas, Columbia University Irving Medical Center, New York, N.Y.email: iat1@columbia.edu Claire Quang Harvard Medical School Columbia...
BioCentury | Aug 27, 2020
Translation in Brief

AbbVie, Harvard in $30M emerging infections partnership, Peel’s cancer therapy from CHOP and Stoke’s Dravet therapy

...Sodium voltage-gated channel alpha subunit 1 Danielle Golovin Stoke Therapeutics Inc. Peel Therapeutics Inc. Children's Hospital of Philadelphia AbbVie Inc. Harvard University Harvard Medical School Sodium...
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...III trial of Moderna’s COVID-19 vaccine, mRNA-1273. Nabel is also a professor of medicine at Harvard Medical School...
BioCentury | Jul 25, 2020
Translation in Brief

New class of cytosine base editors; plus new U.K. vaccine manufacturing facilities, scalable surrogate assay for COVID-19; combating antibiotic resistance and

...SARS-CoV-2 spike protein Danielle Golovin, Staff Writer Chinese Academy of Sciences Agency for Science Technology and Research Massachusetts General Hospital Harvard Medical School Beam...
BioCentury | Jul 23, 2020
Emerging Company Profile

On track for 2021 launch, Seer unveils unbiased proteomics tech and latest $55M round

...City, Calif. Technology: Nanoparticle-based unbiased proteomics assay system Origin of technology: Brigham and Women’s Hospital, Harvard Medical School...
...Founded: 2017 by Omid Farokhzad, Philip Ma, Robert Langer University collaborators: Massachusetts Institute of Technology, Harvard Medical School...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...investigator at the Healey Center for ALS at Mass General and an assistant professor at Harvard Medical School...
BioCentury | Jun 26, 2020
Distillery Therapeutics

AADAC identified as protective factor against diabetic atherosclerosis

...published online May 14, 2020 doi:10.1016/j.stem.2020.04.018 CONTACT: Takafumi Toyohara, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School...
...Center (BIDMC), Harvard Medical School, Boston, Mass.; Harvard University, Cambridge, Mass. email: ccowan@fas.harvard.edu Claire Quang Beth Israel Deaconess Medical Center Harvard Medical School...
BioCentury | Jun 26, 2020
Distillery Therapeutics

Biocryst’s galidesivir effective against Zika in macaques

...published online June 10, 2020 doi:10.1126/scitranslmed.aau9135 CONTACT: James B. Whitney, Beth Israel Deaconess Medical Center, Harvard Medical School...
...Institute of MGH, MIT and Harvard, Cambridge, Mass. email: jwhitne2@bidmc.harvard.edu Claire Quang galidesivir (BCX4430) Beth Israel Deaconess Medical Center Harvard Medical School BioCryst...
BioCentury | Jun 23, 2020
Distillery Therapeutics

Blocking cGAS signaling for alcohol-related liver disease

...Massachusetts General Hospital, Harvard Medical School, Boston, Mass.; Beth Israel Deaconess Medical Center, Boston, Mass. email: sjpatel32@mgh.harvard.edu Claire Quang Harvard Medical School Massachusetts...
BioCentury | May 23, 2020
Product Development

A guide to serum virus neutralization assays

...least 80 if no alternatives are available. On Thursday, a group led by scientists at Harvard Medical School’s...
Items per page:
1 - 10 of 1510